StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Allergan (AGN) Tops Q4 EPS by 14c, Offers Q1 and FY Guidance, Approves $2B Buyback
January 29, 2019 7:04 AM
(Updated - January 29, 2019 7:12 AM EST)Allergan (NYSE: AGN) reported Q4 EPS of $4.29, $0.14 better than the analyst ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Earnings
Guidance
Hot Buybacks
Hot Earnings
Stock Buybacks
Next Articles
Credit Suisse Downgrades Allergen (AGN) to Neutral
January 31, 2019 4:56 AM
Allergen (AGN) PT Lowered to $200 at Mizuho Securities
January 30, 2019 8:21 AM
Allergen (AGN) PT Lowered to $181 at Raymond James
January 30, 2019 7:19 AM
Allergan (AGN) in Final Stages of Selling Antibiotics Divisions, Plans to Keep Women's Health Unit - Bloomberg, Citing Conf. Call
January 29, 2019 8:43 AM
Allergan Reports Fourth Quarter and Full-Year 2018 Financial Results
January 29, 2019 7:01 AM